Tag: Codexis

Codexis product revenue up 227% over last year

Codexis product revenue up 227% over last year

August 8, 2021 |

In California, Codexis, Inc., a leading enzyme engineering company reported record product revenue of $14.7M, up 227% YOY, that drove their product gross margin to a new high of 71%. Product revenues were primarily driven by the sale of enzymes used to manufacture branded pharmaceutical products. “Codexis had an extraordinarily strong second quarter, with record […]

Read More

Codexis raises 2021 guidance following huge new order for proprietary enzyme

Codexis raises 2021 guidance following huge new order for proprietary enzyme

June 20, 2021 |

In California, enzyme engineering company, Codexis, is raising its guidance for 2021, following the receipt of a binding purchase order for up to $13.9 million of a proprietary high performance enzyme product from an undisclosed global pharmaceutical company. The majority of this order was not included in Codexis’ prior guidance for 2021; accordingly, the Company […]

Read More

Codexis total revenue up 23%, product revenue doubles year over year

Codexis total revenue up 23%, product revenue doubles year over year

May 9, 2021 |

In California, enzyme engineering company Codexis reported total revenues for Q1 2021 at $18.0 million, an increase of 23% from $14.7 million in Q1 2020. On a segment basis, $14.2 million in revenue was from the Performance Enzymes segment and $3.8 million was from Novel Biotherapeutics. Product revenues increased 101% to $10.2 million in Q1 […]

Read More

Codexis hits 7th consecutive year of year-over-year revenue growth

Codexis hits 7th consecutive year of year-over-year revenue growth

February 28, 2021 |

In California, Codexis’s 2020 full year product gross margin exceeds 50% for the first time in company’s history and expects 2021 to be strong as well with projected total revenues of $82-85 million and product revenues of $36-39 million, especially thanks to its enzyme engineering platform, CodeEvolver. “Codexis delivered strong results in 2020, despite the […]

Read More

Who’s in Hot Water, Cold Water, and Who’s Just Right?: Mitsubishi, Monolith Materials, Codexis, Casdin, LG Chem, Neste, Wells Fargo, EPA, NXTLEVVEL, Elementis, Growth Energy, US National Labs, Ginkgo Bioworks in the news

Who’s in Hot Water, Cold Water, and Who’s Just Right?: Mitsubishi, Monolith Materials, Codexis, Casdin, LG Chem, Neste, Wells Fargo, EPA, NXTLEVVEL, Elementis, Growth Energy, US National Labs, Ginkgo Bioworks in the news

December 2, 2020 |

Who’s in Hot Water? Some of the Usual Suspects get into the usual trouble. We note that EPA missed the 2021 Renewable Volume Obligation deadline, and Growth Energy threatens a lawsuit. Really. We get tired of reporting on the industry having to (almost annually) sue the government to compel compliance to the law. It’s a […]

Read More

Top 10 Transformations – Pivotal Pivots for survival in the bioeconomy

Top 10 Transformations – Pivotal Pivots for survival in the bioeconomy

July 15, 2018 |

We frequently hear that the only constant is change and in today’s bioeconomy world, we see this lived out all the time. Companies come and go but some evolve, transform, and change. Today we focus on some of these pivotal pivots and the transformations with these leaders who live and breathe change to survive. Some […]

Read More

Welcome to the Protein Revolution: The Digest’s 2017 Multi-Slide Guide to Codexis

Welcome to the Protein Revolution: The Digest’s 2017 Multi-Slide Guide to Codexis

December 1, 2017 |

Codexis is a leading protein engineering company that applies its technology to the development of biocatalysts for the commercial manufacture of pharmaceuticals and fine chemicals. Codexis’ proven technology enables implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable manufacturing. Codexis CEO John Nicols gave this illuminating presentation on the company’s progress, […]

Read More

The Protein Engineers: The Digest’s 2017 Multi-Slide Guide to Codexis

The Protein Engineers: The Digest’s 2017 Multi-Slide Guide to Codexis

September 30, 2017 |

Codexis is a leading protein engineering company that applies its technology to the development of biocatalysts for the commercial manufacture of pharmaceuticals and fine chemicals. Codexis’ proven technology enables implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable manufacturing. This illuminating presentation looks at the company’s progress promise, and most recent […]

Read More

Codexis’s cash flows turn positive ahead of schedule

Codexis’s cash flows turn positive ahead of schedule

August 11, 2014 |

In California, Codexis will be delivering a positive cash flow in 2014 according to recently released financial results for its second quarter. Revenues for the quarter ended June 30, 2014 were $6.6 million, a 6% decrease from $7.0 million of revenues recorded in the second quarter of 2013. According to President and CEO John Nicols, “After delivering results in line […]

Read More

Codexis inks multi-$M GSK deal

Codexis inks multi-$M GSK deal

July 15, 2014 |

In California, Codexis announced the signing of a platform technology license agreement with GlaxoSmithKline (GSK). Under the terms of the agreement, Codexis granted GSK a license to use Codexis’ proprietary CodeEvolver® protein engineering platform technology in the field of human healthcare. The license allows GSK to use Codexis’ platform technology to develop novel enzymes for […]

Read More